A, G., MW, M., N, A., SN, M., BKT, V., B, V., . . . A, P. (2023). Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia-Post hoc exploratory analyses of the COVID STEROID 2 trial. Acta anaesthesiologica Scandinavica, 67(2), 195. https://doi.org/10.1111/aas.14167
Chicago Style (17th ed.) CitationA, Granholm, et al. "Heterogeneous Treatment Effects of Dexamethasone 12 mg Versus 6 mg in Patients with COVID-19 and Severe Hypoxaemia-Post Hoc Exploratory Analyses of the COVID STEROID 2 Trial." Acta Anaesthesiologica Scandinavica 67, no. 2 (2023): 195. https://doi.org/10.1111/aas.14167.
MLA (9th ed.) CitationA, Granholm, et al. "Heterogeneous Treatment Effects of Dexamethasone 12 mg Versus 6 mg in Patients with COVID-19 and Severe Hypoxaemia-Post Hoc Exploratory Analyses of the COVID STEROID 2 Trial." Acta Anaesthesiologica Scandinavica, vol. 67, no. 2, 2023, p. 195, https://doi.org/10.1111/aas.14167.